49 related articles for article (PubMed ID: 15499293)
1. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and Radiation Dosimetry of
Foss CA; Plyku D; Ordonez AA; Sanchez-Bautista J; Rosenthal HB; Minn I; Lodge MA; Pomper MG; Sgouros G; Jain SK
J Nucl Med; 2018 Nov; 59(11):1751-1756. PubMed ID: 29700124
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of
Ranjbar H; Bagheri R; Miremad SM
Appl Radiat Isot; 2024 Jun; 208():111300. PubMed ID: 38531242
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional imaging in cancer-targeted therapy: current applications and future directions.
Bai JW; Qiu SQ; Zhang GJ
Signal Transduct Target Ther; 2023 Feb; 8(1):89. PubMed ID: 36849435
[TBL] [Abstract][Full Text] [Related]
5. Molecular Immune Targeted Imaging of Tumor Microenvironment.
Rakhshandehroo T; Smith BR; Glockner HJ; Rashidian M; Pandit-Taskar N
Nanotheranostics; 2022; 6(3):286-305. PubMed ID: 35223381
[TBL] [Abstract][Full Text] [Related]
6. Molecular Imaging of Angiogenesis in Oncology: Current Preclinical and Clinical Status.
Florea A; Mottaghy FM; Bauwens M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073992
[TBL] [Abstract][Full Text] [Related]
7. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy.
Masłowska K; Halik PK; Tymecka D; Misicka A; Gniazdowska E
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802353
[TBL] [Abstract][Full Text] [Related]
8. Targeted Brain Tumor Radiotherapy Using an Auger Emitter.
Pirovano G; Jannetti SA; Carter LM; Sadique A; Kossatz S; Guru N; Demétrio De Souza França P; Maeda M; Zeglis BM; Lewis JS; Humm JL; Reiner T
Clin Cancer Res; 2020 Jun; 26(12):2871-2881. PubMed ID: 32066626
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of [
Rainer E; Wang H; Traub-Weidinger T; Widhalm G; Fueger B; Chang J; Zhu Z; Marosi C; Haug A; Hacker M; Li S
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2396-2403. PubMed ID: 30062604
[TBL] [Abstract][Full Text] [Related]
10. Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives.
Niccoli Asabella A; Di Palo A; Altini C; Ferrari C; Rubini G
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28846661
[TBL] [Abstract][Full Text] [Related]
11. Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.
Atukorale PU; Covarrubias G; Bauer L; Karathanasis E
Adv Drug Deliv Rev; 2017 Apr; 113():141-156. PubMed ID: 27639317
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.
Zhu H; Zhao C; Liu F; Wang L; Feng J; Zhou Z; Qu L; Shou C; Yang Z
Am J Cancer Res; 2015; 5(11):3301-10. PubMed ID: 26807312
[TBL] [Abstract][Full Text] [Related]
13. Alternative Non-Antibody Protein Scaffolds for Molecular Imaging of Cancer.
Stern LA; Case BA; Hackel BJ
Curr Opin Chem Eng; 2013 Nov; 2(4):. PubMed ID: 24358455
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.
Zhang Y; Hong H; Niu G; Valdovinos HF; Orbay H; Nayak TR; Chen X; Barnhart TE; Cai W
Mol Pharm; 2012 Dec; 9(12):3586-94. PubMed ID: 23137334
[TBL] [Abstract][Full Text] [Related]
15. Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression.
Hao G; Hajibeigi A; León-Rodríguez LM; Oz OK; Sun X
Am J Nucl Med Mol Imaging; 2011; 1(1):65-75. PubMed ID: 23133797
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.
Kang CM; Kim SM; Koo HJ; Yim MS; Lee KH; Ryu EK; Choe YS
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):198-206. PubMed ID: 23096079
[TBL] [Abstract][Full Text] [Related]
17. Imaging key biomarkers of tumor angiogenesis.
Backer MV; Backer JM
Theranostics; 2012; 2(5):502-15. PubMed ID: 22737188
[TBL] [Abstract][Full Text] [Related]
18. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.
Waerzeggers Y; Monfared P; Viel T; Faust A; Kopka K; Schäfers M; Tavitian B; Winkeler A; Jacobs A
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S168-78. PubMed ID: 22433827
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.
Smith RA; Guleryuz S; Manning HC
Front Biosci (Landmark Ed); 2011 Jan; 16(2):393-410. PubMed ID: 21196177
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of angiogenesis with SPECT.
Dijkgraaf I; Boerman OC
Eur J Nucl Med Mol Imaging; 2010 Aug; 37 Suppl 1(Suppl 1):S104-13. PubMed ID: 20617435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
